Phenanthroline

Phenanthroline

SCHEMBL6885504

c1cnc2c(c1)ccc1cccnc12.c1cnc2c(c1)ccc1ccncc12

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.61
CCR8 P51685 5/20 0.61
CCR5 P51681 3/20 0.61
LMNA P02545 3/20 0.61
KDM4E B2RXH2 3/20 0.61
MAPT P10636 3/20 0.61
MMP2 P08253 2/20 0.61
TSHR P16473 2/20 0.61
CYP3A4 P08684 2/20 0.61
HSP90AA1 P07900 2/20 0.61
HTT P42858 2/20 0.61
GMNN O75496 1/20 0.61
TP53 P04637 1/20 0.61
CYP2D6 P10635 1/20 0.61
MMP9 P14780 1/20 0.61
ALOX15 P16050 1/20 0.61
NFKB1 P19838 1/20 0.61
MMP8 P22894 1/20 0.61
THPO P40225 1/20 0.61
MTOR P42345 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29568934 0.98 LMNA (0.58) CCR1CCR8CCR5LMNAKDM4E
SCHEMBL1419171 0.98 LMNA (0.58) CCR1CCR8CCR5LMNAKDM4E
Water SCHEMBL14697038 0.96 LMNA (0.56) CCR1CCR8CCR5LMNAKDM4E
P-Xylene SCHEMBL1420261 0.90 CCR1 (0.51) CCR1CCR8CCR5LMNAKDM4E
O-Xylene SCHEMBL1419625 0.88 CCR1 (0.50) CCR1CCR8CCR5LMNAKDM4E
1-Naphthoquinoline SCHEMBL29094227 0.84 LMNA (0.53) CCR1CCR8CCR5LMNAKDM4E
SCHEMBL14556425 0.83 CCR1 (0.46) CCR1CCR8CCR5LMNAKDM4E
SCHEMBL19652336 0.83 CCR1 (0.46) CCR1CCR8CCR5LMNAKDM4E
SCHEMBL29568930 0.82 LMNA (0.58) CCR1CCR8CCR5LMNAKDM4E
SCHEMBL1419145 0.82 LMNA (0.58) CCR1CCR8CCR5LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699883-B1 ANTIBIOTICS, BACTERICIDES, ANTITUMOR MORPHOCHEM AG (DE) 2004-03-02 US disclosed